The American Society of Hematology (ASH) recognized three researchers from Texas Children’s Cancer Center and Baylor College of Medicine for their work in advancing our understanding of disease pathogenesis and exploring novel innovative approaches for the treatment of pediatric cancers.
Dr. Rikhia Chakraborty, instructor of pediatrics and part of the Histiocytosis Research Lab at the Cancer Center, received a 2016 Basic Junior Faculty Scholar Award for her study investigating disease pathogenesis of Langerhans Cell Histiocytosis, a disease that occurs when the body accumulates too many immature Langerhans cells, a type of white blood cell that normally helps the body fight infection. Scholar awards support fellow and junior faculty dedicated to careers in hematology research as they transition from training programs to careers as independent investigators. The award is for $150,000 over two to three years.
Dr. Maksim Mamonkin, a postdoctoral associate in the Center for Cell and Gene Therapy, received a 2016 Basic Research Fellow Scholar Award for his study on developing targeted therapy to treat T cell malignancies. This research award will provide $100,000 over two to three years and will support transition from training programs to an independent investigator career.
Dr. Rayne Rouce, instructor in the Center for Cell and Gene Therapy, has been named a 2016 award winner of the ASH and the Harold Amos Medical Faculty Development Program of the Robert Wood Johnson Foundation. She delivered a presentation on her work, which focuses on immunotherapy for the treatment of pediatric cancer. She will also receive a $400,000, four-year grant to further her work.